The Technical Analyst
Inspire Medical Systems [INSP]
Exchange: NYSE Sector: Healthcare Industry: Medical Devices
Inspire Medical Systems Price, Forecast, Insider, Ratings, Fundamentals & Signals
-33.47% $163.41
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4 950.88 mill |
| EPS: | -0.710 |
| P/E: | -230.15 |
| Earnings Date: | Jul 30, 2024 |
| SharesOutstanding: | 30.30 mill |
| Avg Daily Volume: | 0.473 mill |
| RATING 2024-05-08 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -230.15 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -230.15 | industry: PE -41.13 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 151.90 - 174.92 ( +/- 7.05%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-05-02 | Burks Cynthia | Buy | 716 | Common Stock |
| 2024-05-02 | Tansey Casey M | Buy | 716 | Common Stock |
| 2024-05-02 | Ellis Gary Lee | Buy | 716 | Common Stock |
| 2024-05-02 | Mead Dana G Jr. | Buy | 716 | Common Stock |
| 2024-05-02 | Curet Myriam | Buy | 716 | Common Stock |
| INSIDER POWER |
|---|
| 5.25 |
| Last 100 transactions |
| Buy: 144 431 | Sell: 125 202 |
Forecast:
16:00 - $163.50
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $163.50
Forecast 2: 16:00 - $163.50
Forecast 3: 16:00 - $163.50
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $163.41 (-33.47% ) |
| Volume | 4.64 mill |
| Avg. Vol. | 0.473 mill |
| % of Avg. Vol | 980.84 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For INSP
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Latest Press Releases
2024-05-07 16:02:00 - Press Release
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results And Updates 2024 Outlook
Inspire reports year-over-year revenue growth of 28% in the first quarter and expects profitability for the full year 2024
2024-04-30 08:00:00 - Press Release
Inspire Medical Systems, Inc. To Present At The Bofa Securities 2024 Health Care Conference
Minneapolis, april 30, 2024 (globe newswire) -- inspire medical systems, inc. (nyse: insp) (inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the bofa securities 2024 health care conference on tuesday, may 14, 2024.
2024-04-02 08:00:00 - Press Release
Inspire Medical Systems, Inc. To Report First Quarter 2024 Financial Results On May 7, 2024
Minneapolis, april 02, 2024 (globe newswire) -- inspire medical systems, inc. (nyse: insp) (inspire) will release financial results for the first quarter 2024 after the close of trading on tuesday, may 7. inspire's management team will host a corresponding conference call beginning at 5:00 p.m. eastern time to discuss the financial results and recent business developments.
2024-03-05 08:00:00 - Press Release
Inspire Medical Systems, Inc. To Present At The keybanc Life Sciences & Medtech Investor Forum
Minneapolis, march 05, 2024 (globe newswire) -- inspire medical systems, inc. (nyse: insp) (inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the keybanc life sciences and medtech investor forum on tuesday, march 19, 2024.
2024-02-20 12:15:00 - Press Release
Inspire Medical Systems, Inc. Sued For Securities Law Violations – Investors Should Contact Levi & Korsinsky For More Information - Insp
New york, ny / accesswire / february 20, 2024 / if you suffered a loss on your inspire medical systems, inc. (nyse:insp) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-lawsuit-submission-form?prid=67560&wire=1 or contact joseph e. levi, esq.
Latest News
2024-05-08 12:36:06 - Zacks Investment Research
Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
2024-05-08 10:36:20 - Zacks Investment Research
Inspire (INSP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
2024-05-07 22:38:02 - Seeking Alpha
Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Ezgi Yagci - VP, IR Tim Herbert - Chairman and CEO Rick Buchholz - CFO Conference Call Participants Danielle Antalffy - UBS Travis Steed - Bank of America Adam Maeder - Piper Sandler Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Anthony Petrone - Mizuho Chris Pasquale - Nephron Richard Newitter - Truist Securities Shagun Singh - RBC John Block - Stifel Mike Kratky - Leerink Partners Michael Sarcone - Jefferies Larry Biegelsen - Wells Fargo Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer Operator Good afternoon. My name is [Dilem], and I'll be your conference operator today.
2024-05-07 18:11:06 - Zacks Investment Research
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.53 per share a year ago.
2024-05-03 10:21:11 - Zacks Investment Research
Gear Up for Inspire (INSP) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Inspire (INSP) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
2024-04-30 08:00:00 - GlobeNewsWire
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.
2024-04-18 13:21:17 - Zacks Investment Research
Why You Should Add Inspire Medical (INSP) to Your Portfolio
2024-04-18 03:16:13 - Zacks Investment Research
Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains?
Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
2024-04-09 07:16:03 - Zacks Investment Research
New Strong Buy Stocks for April 9th
SRDX, X, TELNY, INSP and MTAL have been added to the Zacks Rank #1 (Strong Buy) List on April 9, 2023.
2024-03-20 15:01:12 - Zacks Investment Research
3 Medical Info Systems Stocks to Buy as Industry Improves
A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.